Concurrent Treatment of Substance Abuse and Child Maltreatment

NCT ID: NCT02774525

Last Updated: 2021-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The co-occurrence of child maltreatment and parental substance-use problems is a major public health problem with serious consequences for children, parents, families, and the community at large. The need for effective dual treatment of caregiver substance abuse and child maltreatment is unquestionable, but there is a dearth of controlled treatment outcome studies with substance-using parents who have engaged in child maltreatment. This project examines two evidence-based treatments-Contingency Management for substance-use problems and Pathways Triple P parenting intervention to improve parenting for prevention of child-maltreatment recurrence. These two systematic interventions are being tested in the context of traditional outpatient treatment for substance-use problems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Use Child Maltreatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment as Usual (TAU)

Outpatient substance-abuse treatment plus drug and alcohol screening plus brief support for personal goal setting

Group Type ACTIVE_COMPARATOR

Treatment as usual (TAU)

Intervention Type BEHAVIORAL

Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting

Contingency Management

Contingency management for drug and alcohol abstinence plus TAU

Group Type EXPERIMENTAL

Reinforcement for drug & alcohol abstinence

Intervention Type BEHAVIORAL

Treatment as usual (TAU)

Intervention Type BEHAVIORAL

Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting

Parenting Intervention

Parenting intervention plus TAU

Group Type EXPERIMENTAL

Parenting intervention

Intervention Type BEHAVIORAL

Treatment as usual (TAU)

Intervention Type BEHAVIORAL

Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting

Parenting Intervention + Contingency Management

Parenting intervention plus contingency management for drug and alcohol abstinence plus TAU

Group Type EXPERIMENTAL

Reinforcement for drug & alcohol abstinence

Intervention Type BEHAVIORAL

Parenting intervention

Intervention Type BEHAVIORAL

Treatment as usual (TAU)

Intervention Type BEHAVIORAL

Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reinforcement for drug & alcohol abstinence

Intervention Type BEHAVIORAL

Parenting intervention

Intervention Type BEHAVIORAL

Treatment as usual (TAU)

Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Contingency management for negative drug & alcohol samples Pathways Triple P

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* open child protective services case for child maltreatment
* beginning intensive outpatient treatment for drug or alcohol use problem
* at least one child 2-8 years of age

Exclusion Criteria

* not primary custodial parent for child 2-8 years of age
* serious mental illness
* residing outside the two participating counties
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ron Prinz, PhD

Carolina Distinguished Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ron Prinz, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of South Carolina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of South Carolina Parenting & Family Res Center

Columbia, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00015175

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.